|
|
Volumn 371, Issue 8, 2014, Pages 781-784
|
|
Treatments for idiopathic pulmonary fibrosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NINTEDANIB;
PIRFENIDONE;
PLACEBO;
ANTIFIBRINOLYTIC AGENT;
ENZYME INHIBITOR;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDONE DERIVATIVE;
CLINICAL TRIAL (TOPIC);
DRUG EFFICACY;
DRUG SAFETY;
FIBROSING ALVEOLITIS;
FORCED VITAL CAPACITY;
HUMAN;
LETTER;
OUTCOME ASSESSMENT;
PREDICTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
FEMALE;
MALE;
NOTE;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG RESPONSE;
LUNG NON SMALL CELL CANCER;
OVERALL SURVIVAL;
PROGRESSION FREE SURVIVAL;
RASH;
RISK ASSESSMENT;
ANTIFIBRINOLYTIC AGENTS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
IDIOPATHIC PULMONARY FIBROSIS;
INDOLES;
MALE;
PROTEIN KINASE INHIBITORS;
PYRIDONES;
|
|
EID: 84906898062
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1407776 Document Type: Letter |
|
Times cited : (8)
|
|
References (3)
|
